Erythromycin Monotherapy Associated with Torsade de Pointes

This publication has 12 references indexed in Scilit:

• Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.
  Circulation, 1993
• Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin
  Clinical Pharmacology & Therapeutics, 1992
• Possible risk for cardiac arrhythmia related to intravenous erythromycin
  Intensive Care Medicine, 1992
• Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiologic mechanism
  The American Journal of Medicine, 1990
• Torsades de pointes associated with drugs and toxins: Recognition and management
  American Heart Journal, 1987
• Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome
  The American Journal of Cardiology, 1987
• QT prolongation and recurrent “torsades de pointes” during erythromycin lactobionate infusion
  The American Journal of Cardiology, 1986
• Clinical features and basic mechanisms of quinidine-induced arrhythmias
  Journal of the American College of Cardiology, 1986
• TORSADE DE POINTES: DEFINITIONS, CAUSATIVE FACTORS, AND THERAPY: EXPERIENCE WITH SIXTEEN PATIENTS
  Annals of the New York Academy of Sciences, 1984
• Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin
  The American Journal of Cardiology, 1984